Aptamers in Neuroscience
In this whitepaper, we present recent advances in aptamer generation discussing merits and limitations. Emphasis is placed on applications for diseases including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis and other diseases stemming from protein aggregation.
Aptamers and Cancer Immunotherapy
This article discusses the strategies for using aptamers as treatments for immune regulators and the potential for them as an alternative to monoclonal antibodies.
Novel penumoniae Diagnostics
Aptamers have been proving to be a very strong tool for diagnostic techniques. This review discusses new developments in different penumoniae diagnostic tests.
Aptabind™ is our state of the art protein purification technique. Specifically designed to target the protein you want in the buffer or matrix conditions you desire.
Click here to download some information about AptaBind™: Aptamer Group – Aptabind™
Selecting Aptamers to Small Molecules
At Aptamer Group, we employ state-of-the-art methods to select and identify aptamers to small molecule targets. These aptamers can then be modified to achieve goals that are often not possible with other methods.
Click here to find out more about how we select aptamers to small molecules: Aptamer Group – Small Molecule Selection
Affinity Reagents and Reproducibility
This white paper outlines the differences between antibodies and aptamers with regards to reproducibility.
Aptamers and Cardiovascular Disease
This article outlines how aptamers can be used to identify new biomarkers and as a diagnostic tool.
Aptamers and Biosensors
This white paper goes into detail on how aptamers can be used to develop biosensors. It describes 3 different methods for using aptamers in biosensors.